Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
Clinical trial NCT02452034 · COMPLETED
Trial details
- NCT number
- NCT02452034
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-07
- Primary completion
- 2018-06-26
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.